Clinical Trials Browser

Phase 2 × Completed × Metastatic Castrate Resistant Prostate Cancer (mCRPC) × Clear all

NCT03899467 2024-02-12

The Safety and Tolerability of GT0918 in Subjects With mHSPC and mCRPC

Phase 2 Completed

61 enrolled 12 charts

Metastatic Castrate Resistant Prostate Cancer (mCRPC)